EducationalSymposia-rp
Description
Room: 309 (Level 300)
BRIDGING THE GAP BETWEEN RETROSPECTIVE DATA AND REGISTRIES: WHERE DO WE GO FROM HERE?
Real-world data (RWD) and real-world evidence (RWE) are playing an increasing role in healthcare decision making for both regulators dealing with safety and approval, and payers dealing with access. While automated healthcare databases (electronic health records, claims, etc) are good ow-budget resources, they often lack some of the key elements required for evidence generation. Patient registries can be expensive, requiring extensive resources and time, which delay critical decision making. In this session, our panel of stakeholders will address the: (1) current approaches utilized for generating RWE, and (2) what gaps can be addressed using methodologies that are reasonable with regard to cost, time, and resources, without compromising the robustness of evidence.

Moderator: Christopher M Blanchette, PhD, MBA
Senior Vice President, Global Evidence, Value and Access, Ipsos Healthcare, New York, NY, USA

Speaker: Jeffrey Vernice, PhD, MBA, MS
Senior Director, Analytics Business Partner and Data Science, Horizon Blue Cross Blue Shield of New Jersey, Newark, NJ, USA

Speaker: Elaine B. Yu, PharmD, MS
Head of Evidence for Access BioOncology, Genentech, Inc., South San Francisco, CA, USA

Speaker: Joshua M Noone, PhD
Director, Global Evidence, Value and Access, Ipsos Healthcare, New York, NY, USA

Speaker: Emily Zacherle, MS
Senior Research Manager, Global Evidence, Value and Access, Ipsos Healthcare, New York, NY, USA

Ipsos Healthcare
(Sponsored by Ipsos Healthcare)
Tags